Why did JNHMF stock fall 95% on 06 Mar 2026?

The decline reflects very low liquidity, a sharp gap down from **$0.0171** to **$0.0008**, and likely short-term selling pressure; with only **1,000** shares traded versus an average of **36**, price impact was extreme.

What is Meyka AI's view on JNHMF stock?

Meyka AI rates JNHMF with a score out of 100 at **66.33** (Grade B, HOLD). The model flags mixed fundamentals, low liquidity, and a speculative technical setup; this is analysis, not advice.

What price targets exist for JNHMF stock?

Meyka AI's forecast model projects **$0.0100** monthly. Conservative scenarios place a nearer-term price target at **$0.0050** and a downside test near **$0.0005**; forecasts are projections, not guarantees.

Is JNHMF stock suitable for retail portfolios?

Given microcap status on PNK, extreme volatility, and thin volume, JNHMF stock is suitable only for speculative allocations with strict position sizing and stop-loss rules.

US Stocks

JNHMF Jack Nathan Medical (PNK) drops 95% to $0.0008 on 06 Mar 2026: risk signal

ByHuzaifa Zahoor March 6, 2026March 6, 2026

The microcap JNHMF stock plunged 95.32% to $0.0008 in market hours on 06 Mar 2026, making it one of the session’s top losers. The move followed a gap from $0.0171 and traded just 1,000 shares versus a 50-day average of 36 shares, signaling heightened short-term activity. Jack Nathan Medical Corp. (PNK) now sits near its year low of $0.0008 while average prices remain at $0.00644 (50-day) and $0.00528 (200-day). We summarize why the sell-off matters for traders and longer-term investors.